Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vignesh Sivaganesh
Institutions:
Philadelphia College of Osteopathic Medicine,
Saint Joseph's University
Observed institutions:
Philadelphia College of Osteopathic Medicine,
University of the Sciences,
University of California San Diego,
Saint Joseph's University
ORCID:
0000-0003-1775-6640
Observed ORCID:
0000-0003-1775-6640
OpenAlex ID:
A5031426654
A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy
2016
·
Rohith Srivas
, John Paul Shen
, et al.
·
Molecular Cell
·
151
PDF
Diet and feeding pattern modulate diurnal dynamics of the ileal microbiome and transcriptome
2022
·
Ana Carolina Dantas Machado
, Steven D. Brown
, et al.
·
Cell Reports
·
121
PDF
Protein Tyrosine Phosphatases: Mechanisms in Cancer
2021
·
Vignesh Sivaganesh
, Varsha Sivaganesh
, et al.
·
International Journal of Molecular Sciences
·
72
PDF
Emerging Immunotherapies against Novel Molecular Targets in Breast Cancer
2021
·
Vignesh Sivaganesh
, Nazifa Promi
, et al.
·
International Journal of Molecular Sciences
·
27
PDF
Chemogenetic profiling identifiesRAD17as synthetically lethal with checkpoint kinase inhibition
2015
·
John Paul Shen
, Rohith Srivas
, et al.
·
Oncotarget
·
16
PDF
Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer
2023
·
Vignesh Sivaganesh
, Bela Peethambaran
·
Exploration of Targeted Anti-tumor Therapy
·
11
PDF
Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway
2024
·
Vignesh Sivaganesh
, Tram M. Ta
, et al.
·
International Journal of Molecular Sciences
·
9
PDF
Structure–activity relationship of 2-aminodibenzothiophene pharmacophore and the discovery of aminobenzothiophenes as potent inhibitors of Mycobacterium smegmatis
2022
·
Sawsan H. Alelaiwi
, Jason E. Heindl
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
2
Abstract 129: RAD17 loss of function is synthetically lethal with the checkpoint kinase inhibitors AZD7762 or MK-1775
2015
·
John Paul Shen
, Rohith Srivas
, et al.
·
Cancer Research
·
1
Receptor Tyrosine Kinase‐like Orphan Receptor 1 (ROR1) as a Selective Molecular Target in Androgen‐Dependent and Androgen‐Independent Prostate Cancer
2021
·
Vignesh Sivaganesh
, Nazifa Promi
, et al.
·
The FASEB Journal
Inhibiting ROR1 expression in Androgen-Independent Prostate Cancer Reduces Aggressive Cancer Phenotypes by modulation of AKT-GSK3ꞵ Pathway
2021
·
Vignesh Sivaganesh
, Nazifa Promi
, et al.
·
Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)
350 – Gwas-Identified Metabolic Syndrome Genes are Tightly Linked to Race
2019
·
Neela Easwar
, Steven D. Brown
, et al.
·
Gastroenterology
Show more works
View as search
Works count:
12
Citation count:
410
H-index:
7
I10-index:
6
Year
Topic
Type